Document Detail


In vivo antibacterial efficacy of MONOCRYL plus antibacterial suture (Poliglecaprone 25 with triclosan).
MedLine Citation:
PMID:  17437366     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: This study evaluated the ability of poliglecaprone 25 suture with triclosan to inhibit bacterial colonization by Escherichia coli and Staphylococcus aureus in mouse and guinea pig models. METHODS: Test and control sutures (3-4 cm) were implanted subcutaneously in the dorsal-lateral regions (control on the left side, test on the right side, approximately 3-5 cm apart) in 10 female Hartley guinea pigs (300-400 g) and 10 Swiss Webster mice (20-35 g) via a 20-gauge catheter. The test material was poliglecaprone 25 suture with triclosan (2-0, undyed), and the control material was poliglecaprone 25 suture (2-0, undyed). In the guinea pig model, each implantation site was challenged directly with 4x10(5) colony-forming units (cfu) of S. aureus, whereas in the mouse model, each implantation site was challenged directly with 1.3x10(7) cfu of E. coli through an indwelling catheter. At 48 h post-implantation, the control and test sutures were explanted, and bacterial enumeration was performed. RESULTS: There was a significant difference (p < 0.05) in the number of bacteria recovered in the study groups 48 h post-implantation. Poliglecaprone 25 suture with triclosan produced a 3.4-log reduction in S. aureus and a 2-log reduction in E. coli compared with standard poliglecaprone 25 suture without triclosan under the same challenge conditions. The difference between the study groups in the number of bacteria recovered was significant (p < 0.05). CONCLUSION: Poliglecaprone 25 suture with triclosan inhibited bacterial colonization of the suture compared with untreated suture after direct in vivo challenge with S. aureus and E. coli in animal models.
Authors:
Xintian Ming; Michele Nichols; Stephen Rothenburger
Related Documents :
25343576 - The enhancement of osteogenesis and biodegradation control by brushite coating on mg-nd...
25407446 - Vancomycin containing plla/ß-tcp controls experimental osteomyelitis in vivo.
3579996 - Comparison of the dielectric properties of normal and wounded human skin material.
1542066 - The relationship of cigarette smoking to impaired intraoral wound healing: a review of ...
2708506 - Successful embryo transfer of cryopreserved and in-vitro fertilized rabbit oocytes.
3997526 - Comparison of environmental radiation dosimetry and gamma-ray spectroscopy.
Publication Detail:
Type:  Evaluation Studies; Journal Article    
Journal Detail:
Title:  Surgical infections     Volume:  8     ISSN:  1096-2964     ISO Abbreviation:  Surg Infect (Larchmt)     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-04-17     Completed Date:  2007-05-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9815642     Medline TA:  Surg Infect (Larchmt)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  209-14     Citation Subset:  IM    
Affiliation:
Corporate Microbiology and Sterilization Sciences, Ethicon Inc, Somerville, NJ 08876, USA. xming@ethus.jnj.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anti-Infective Agents, Local / pharmacology*
Bacterial Adhesion / drug effects*
Coated Materials, Biocompatible
Colony Count, Microbial
Dioxanes*
Escherichia coli / drug effects
Female
Guinea Pigs
Mice
Microbial Sensitivity Tests / methods
Polyesters*
Staphylococcus aureus / drug effects
Surgical Wound Infection / prevention & control*
Sutures / microbiology*
Triclosan / pharmacology*
Chemical
Reg. No./Substance:
0/Anti-Infective Agents, Local; 0/Coated Materials, Biocompatible; 0/Dioxanes; 0/Polyesters; 3380-34-5/Triclosan; 41706-81-4/glycolide E-caprolactone copolymer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  In vitro antibacterial efficacy of MONOCRYL plus antibacterial suture (Poliglecaprone 25 with triclo...
Next Document:  Evaluating empiric treatment options for secondary peritonitis using pharmacodynamic profiling.